Control of Papillomavirus Expression and Transformation
Control of Papillomavirus Expression and Transformation
批准号:
7848623
负责人:
ELLIOT J. ANDROPHY
金额:
$0.95万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-06-01 至 2009-10-31
关键词:
AddressAffinityAmino AcidsAnaphaseApplications GrantsBenignBindingBiologicalBiologyC-terminalCell CycleCell Cycle ProgressionCell SurvivalCellsChromatinChromatin Remodeling FactorChromosomesComplexCytokinesisDNA biosynthesisDevelopmentEpisomeEpithelial CellsGene ExpressionGenetic TranscriptionGenomeGoalsHuman PapillomavirusInfectionInvestigationKinesinKinetochoresLeadLocationMaintenanceMalignant - descriptorMalignant NeoplasmsMalignant neoplasm of cervix uteriMediatingMitosisMitoticMitotic CheckpointMitotic ChromosomeMitotic spindleMolecularMutationN-terminalNatureNucleosomesOncogenicPapillomavirusPathway interactionsPhaseProcessPropertyProteinsReplication OriginRepressionResearch PersonnelRoleStagingTestingTransactivationTranscriptional ActivationTranscriptional RegulationViralViral Gene Expression RegulationViral GenomeViral PathogenesisVirusbrahmachromatin remodelingcohesinhelicasein vivoinsightkeratinocytenovelprogramspromoterprotein complexprotein protein interactionresearch studytumor progressionviral DNA
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The E2 protein regulates transcription and replication of the papillomavirus genome as a stable episome. Its N-terminal domain binds cellular factors and complexes necessary for these functions. These cellular proteins are targeted to the viral genome by the E2 C-terminal domain, which binds with high affinity to specific sequences in the viral DNA. The goal of this grant proposal is to identify and characterize the cellular proteins and pathways through which E2 actuates its diverse functions. The first Aim investigates the activities of E2 during cell cycle, when E2 localizes the viral E1 DNA helicase to the origin in S phase, and in mitosis when E2 tethers the viral genome to host chromosomes, mediates its partitioning, and as we propose here, abrogates mitotic checkpoints that might otherwise restrict host cell viability. We demonstrate E2 interactions with several mitotic proteins that will be further characterized in this Aim. These protein- protein interactions reveal novel mechanisms for viral genome attachment to chromosomes during mitosis. Other interactions suggest a mechanism to transport the viral genome on the mitotic spindle. Another goal of this aim is to investigate the ability of E2 to inhibit mitotic checkpoints. In one example, we test the hypothesis that E2 inhibits cytokinesis, a function that is probably necessary for viral genome amplification in differentiated epithelial cells. Loss of these E2 functions following viral genome integration and disruption of E2 may represent an important step in neoplastic progression by oncogenic human papillomaviruses. Aim 2 continues our investigations of the mechanism of transcriptional regulation, with particular emphasis on how E2 overcomes chromatin repression in vivo. We test the hypothesis that E2 interactions with components of the Swi/Snf chromatin-remodeling complex are necessary for transcriptional activation and repression. These studies will broaden our understanding of the molecular functions of E2 in the viral replicative program.
Lay Statement: Papillomaviruses cause benign infections that can become malignant, and are the etiologic agent of cervical cancer. The E2 protein controls essential functions of the virus. We propose to identify the proteins in the cell that interact with E2 and their functions. These are involved in fundamental process including gene expression and DNA replication. Understanding how E2 operates will provide insights into the biology of these pathways and infer how aberrations may occur that lead to the development of cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Small Molecule E6 Inhibitors to Treat Oropharyngeal Cancers Caused by HPV Infections
-
批准号:10484043
-
项目类别:
-
资助金额:$27.58万
-
财政年份:2022
-
负责人:ELLIOT J. ANDROPHY
-
依托单位:
Small Molecule E6 Inhibitors to Treat Dysplasia Caused by HPV Infections
-
批准号:10390563
-
项目类别:
-
资助金额:$29.85万
-
财政年份:2022
-
负责人:ELLIOT J. ANDROPHY
-
依托单位:
Development of a mouse model to test HPV Antiviral compounds
-
批准号:10582890
-
项目类别:
-
资助金额:$19.81万
-
财政年份:2022
-
负责人:ELLIOT J. ANDROPHY
-
依托单位:
Small-Molecule Covalent E6 Antagonists for Treatment of HPV Infection
-
批准号:10220227
-
项目类别:
-
资助金额:$63.29万
-
财政年份:2021
-
负责人:ELLIOT J. ANDROPHY
-
依托单位:
Small-Molecule Covalent E6 Antagonists for Treatment of HPV Infection
-
批准号:10610388
-
项目类别:
-
资助金额:$60.72万
-
财政年份:2021
-
负责人:ELLIOT J. ANDROPHY
-
依托单位:
Small-Molecule Covalent E6 Antagonists for Treatment of HPV Infection
-
批准号:10397131
-
项目类别:
-
资助金额:$64.51万
-
财政年份:2021
-
负责人:ELLIOT J. ANDROPHY
-
依托单位:
Optimization of a novel series of thiazolopyridines for the treatment of SMA
-
批准号:8892548
-
项目类别:
-
资助金额:$44.76万
-
财政年份:2015
-
负责人:ELLIOT J. ANDROPHY
-
依托单位:
Toward drug treatment of spinal muscular atrophy: Mechanism of action
-
批准号:8823350
-
项目类别:
-
资助金额:$26.07万
-
财政年份:2014
-
负责人:ELLIOT J. ANDROPHY
-
依托单位:
The COPA vesicle protein and pathogenesis of spinal muscular atrophy
-
批准号:8866202
-
项目类别:
-
资助金额:$34.08万
-
财政年份:2013
-
负责人:ELLIOT J. ANDROPHY
-
依托单位:
The Indiana Cutaneous Biological Research Training Program
-
批准号:8827676
-
项目类别:
-
资助金额:$11.45万
-
财政年份:2013
-
负责人:ELLIOT J. ANDROPHY
-
依托单位:
The COPA vesicle protein and pathogenesis of spinal muscular atrophy
-
批准号:10612848
-
项目类别:
-
资助金额:$38.22万
-
财政年份:2013
-
负责人:ELLIOT J. ANDROPHY
-
依托单位:
The COPA vesicle protein and pathogenesis of spinal muscular atrophy
-
批准号:10399511
-
项目类别:
-
资助金额:$38.48万
-
财政年份:2013
-
负责人:ELLIOT J. ANDROPHY
-
依托单位:
The COPA vesicle protein and pathogenesis of spinal muscular atrophy
-
批准号:9924683
-
项目类别:
-
资助金额:$38.64万
-
财政年份:2013
-
负责人:ELLIOT J. ANDROPHY
-
依托单位:
The COPA vesicle protein and pathogenesis of spinal muscular atrophy
-
批准号:8628535
-
项目类别:
-
资助金额:$34.09万
-
财政年份:2013
-
负责人:ELLIOT J. ANDROPHY
-
依托单位:
The COPA vesicle protein and pathogenesis of spinal muscular atrophy
-
批准号:9274418
-
项目类别:
-
资助金额:$5.57万
-
财政年份:2013
-
负责人:ELLIOT J. ANDROPHY
-
依托单位:
The COPA vesicle protein and pathogenesis of spinal muscular atrophy
-
批准号:8719190
-
项目类别:
-
资助金额:$33.75万
-
财政年份:2013
-
负责人:ELLIOT J. ANDROPHY
-
依托单位:
The Indiana Cutaneous Biological Research Training Program
-
批准号:9244754
-
项目类别:
-
资助金额:$11.73万
-
财政年份:2013
-
负责人:ELLIOT J. ANDROPHY
-
依托单位:
Cooperative lead development program for treatment of spinal muscular atrophy
-
批准号:7866212
-
项目类别:
-
资助金额:$71.06万
-
财政年份:2010
-
负责人:ELLIOT J. ANDROPHY
-
依托单位:
Cooperative lead development program for treatment of spinal muscular atrophy
-
批准号:8302317
-
项目类别:
-
资助金额:$59.66万
-
财政年份:2010
-
负责人:ELLIOT J. ANDROPHY
-
依托单位:
Cooperative lead development program for treatment of spinal muscular atrophy
-
批准号:8139203
-
项目类别:
-
资助金额:$64.05万
-
财政年份:2010
-
负责人:ELLIOT J. ANDROPHY
-
依托单位:
海外基金